AGXT2 metabolizes ADMA to ADGV (asymmetricα-keto-dimethylguanidinovaleric acid) which later can be excreted [37, 38] and decreased AGXT2 enzyme activity causes ADMA accumulation, leading to renal disease development. The gene discussed is AGXT2; the disease is kidney disorder.